Human recombinant ENA 78/CXCL5 (from E. coli)
Lieferant: Shenandoah Biotechnology
Epithelial-derived neutrophil-activating peptide 78 (ENA 78), also known as CXCL5, is a chemokine that recruits neutrophils, promotes angiogenesis.
- Produced from genetically modified E. coli
- Stimulates connective tissue remodelling
- Monomeric protein, contains 74 amino acids
ENA 78 production is stimulated by interleukin 1 (IL-1) or tumor necrosis factor alpha (TNFα), and signals through the chemokine receptor CXCR2.
ENA 78, 5-78 aa is one of three naturally occurring ENA 78 variants in which the N-terminus has been truncated.
Lieferumfang: A Certificate of Analysis (COA) is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.
Bitte beachten This product is for research use only and is not for use in humans.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...